Company intelligence / Profile preview
Cabaletta Bio
Philadelphia, Pennsylvania, United Statescabalettabio.com ↗
- Ownership
- Public · CABA
- Development stage
- Other
01
Overview
Cabaletta Bio has demonstrated favorable safety and promising early efficacy in its RESET™ program with rese-cel (formerly CABA‑201), a CD19-CAR T cell therapy. Early data show that a single weight-based dose can provide transformative responses in autoimmune diseases after discontinuation of immunosuppressants, with most patients experiencing minimal or no cytokine release syndrome or neurotoxicity. The company continues to expand enrollment across multiple indications and geographies, with registrational trial discussions ongoing for myositis[4][5][6].
- Therapeutic areas
- ImmunologyNeurologyRheumatology
- Modalities
- Engineered T cell therapiesCAR-T cells (CD19-CAR T)CAART (Chimeric AutoAntibody Receptor T cells)
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Financials
- Market cap
- $217M
- Total revenue
- $0
- Enterprise value
- $-59.2M
Beyond the preview
Go deeper on Cabaletta Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cabaletta Bio.